Introduction:
There is a spectrum of microdeletion syndromes associated with 17p13.3 deletions. MillerDieker syndrome (OMIM#247200) occurs when a deletion includes YWHAE and PAFAH1B1 (LIS1). Isolated lissencephaly sequence (OMIM#6074332) occurs with smaller deletions involving PAFAH1B1 but not YWHAE. 1 Individuals with smaller deletions including YWHAE and CRK but sparing LIS1 have growth restriction, cognitive impairment, dysmorphic features, and various brain abnormalities. [2] [3] [4] [5] White matter abnormalities have been reported in some patients with 17p13.3 microdeletions, and previous literature has hypothesized that this may be related to YWHAE haploinsufficiency. [2] [3] [4] 6 We report a cohort of children who present with primarily white matter changes on brain MRI with mild dysmorphic features but no growth restriction or significant cognitive impairment with small interstitial 17p13.3 microdeletions. The patients have a primary static leukoencephalopathy with hypermobile joints but no evidence of developmental regression. The deletions are all proximal to CRK, which has been hypothesized to be associated with short stature, 2, 3 and distal to PAFAH1B1, associated with lissencephaly.
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Materials & Methods:
Patient ascertainment Patient 1 enrolled in the Undiagnosed Diseases Network (UDN) with a known chromosomal deletion involving 17p13.3, since the pathogenicity of the deletion and the etiology of her disease was not well established. Review of Baylor Genetics cytogenetic database for patients with similar deletions limited to the region between YWHAE/CRK and PAFAH1B1 identified three other patients with white matter changes and one patient with a normal brain MRI. Two of these patients were brothers (Patients 2-3) and also enrolled in the UDN. A literature search with 17p13 search terms was used to identify other reports of similar white matter changes with deletions involving this region. The DECIPHER database was also searched for similar patients with deletions in the same region, although no individuals were identified with reported similar white matter changes.
Chromosomal microarray testing
The patients were studied by either V8, V9, or V10 chromosomal microarrays (CMAs) designed by Baylor Medical Genetics Laboratories and manufactured by Agilent (Santa Clara, CA, USA).
Patients 2, 4, and 5 were studied by the V8 array which included approximately 180,000
interrogating oligonucleotides, selected from Agilent's online library (eArray;
https://earray.chem.agilent.com/earray/). About 1,714 genes were covered on this array with an average of 4.2 probes per exon, excluding low-copy repeats and other repetitive sequences.
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Patients 3 and 1 were studied by the V9 and V10 array respectively, which targeted over 4,900 genes at the exon level plus 60,000 probes used for SNP analysis for the detection of uniparental disomy and absence of heterozygosity. 8 
Whole exome sequencing
Clinical whole exome sequencing (WES) was performed in Patients 1 and 2 according to previously described methods. Figure 1D , Table 1 ). WES did not show any pathogenic variants or candidate genes associated with white matter changes or hypermobility, nor rare variants in the non-deleted 17p13.3 alleles. MRIs and MR spectroscopy showed no progression of these white matter changes. He has a normal IQ (100, at age 6) and was diagnosed with ADHD at age 8 with no additional concerns for regression. Physical exam showed macrocephaly with frontal bossing, hypermobile joints (Beighton score 6/9), and progressive pes planus. There was concern for connective tissue disorder, but echocardiogram and eye exam were normal. Genetic workup included normal urine mucopolysaccharide screening, serum very long chain fatty acids and arylsulfatase activity.
CMA showed a 0.8 Mb 17p13.3 deletion ( Figure 1D , Table 1 ) and a small deletion on 15q11.2 including only non-coding exons of SNRPN. The 17p13.3 deletion was inherited from his father and shared with a younger brother (Patient 3). Their father may also be similarly affected. He had problems with rolling his ankles when he was younger, as well as behavior issues. He has a cranial metal plate after a motor vehicle accident and therefore is unable to obtain a brain MRI, but a CT scan at the time of the accident showed white matter changes; additional details are not available. In Patient 2, WES did not show any pathogenic variants or candidate genes associated with white matter changes or hypermobility, nor rare variants in the non-deleted 17p13.3 alleles.
Patient 3 was born full-term to a 28-year-old mother with normal delivery and newborn course.
He weighed 2.95kg (20%). He met all of his early milestones. Brain MRI at 3 years, performed due to macrocephaly and his brother's MRI findings, showed patchy punctate bilateral multifocal areas of T2 hyperintensities ( Figure 1C ) and 2 small arachnoid cysts. Multiple subsequent brain
MRIs and MR spectroscopy showed no progression of the white matter changes. His exam is significant for head circumference >98% with frontal bossing, hypermobile joints (Beighton score 6/9), and progressive pes planus. Echocardiogram showed mild mitral and tricuspid regurgitation. Ophthalmology noted mild hyperopia not requiring any intervention. Hyperkinetic behaviors were noted at 3 to 4 years old, and he was diagnosed with ADHD at age 5. Sleep study showed both mild central and obstructive sleep apnea and decreased time in REM sleep.
Patient 4 is a 3-year-old male. MRI showed periventricular leukomalacia. CMA showed a 0.7
Mb maternally inherited 17p13.3 deletion ( Figure 1D , Table 1 Figure 1D , Table 1 ).
Discussion
Microdeletion syndromes involving 17p13.3 have a range of phenotypes, with the most severe being Miller-Dieker syndrome, with primary lissencephaly, growth failure, intellectual disability and dysmorphic features. 1 Genotype-phenotype correlations have elucidated the roles of genes:
PAFAH1B1 involved in brain development 1 and CRK in short stature. 2, 3 White matter changes have also been reported in some individuals with microdeletions in this region ( Figure 1D , Table   S1 ). [2] [3] [4] We report a small cohort of children with white matter lesions, normal cognition and hypermobile joints with small 17p13.3 microdeletions between and not including YWHAE/CRK and PAFAH1B1. Previous literature has speculated a possible role for YWHAE in the brain anomalies, including the white matter changes. [2] [3] [4] 6 Our cohort suggests a different gene is likely responsible for the white matter findings, although it is likely that multiple 17p13.3 genes contribute to brain development. Due to the normal MRI in patient 5, whose deletion includes all genes in the smallest region of overlap (SRO) for this phenotype ( Figure 1D ), reduced penetrance is likely for these white matter changes.
White matter changes in the brain are often concerning for possible neurodegenerative leukodystrophy. Our cohort demonstrates that white matter changes can be associated with static, less severe conditions. The lesions in Patients 1-3 appear to be static based on multiple brain
MRIs in each patient and the likely presence of similar findings in the father of Patients 2 and 3.
Similar white matter changes have been described in individuals with other copy number variants (CNVs) that may contribute to their brain changes, although for the most part no causative genes have been confirmed within CNVs. 10 Exceptions include haploinsufficiency of MBP (myelin basic protein) in 18q23 deletions and truncating deletions of TM4SF20, which have been linked to white matter changes on MRI. 11, 12 There are eleven RefSeq genes, SERPINF1, SMYD4, RPA1, RTN4RL1, LOC105371485, DPH1, OVCA2, MIR132, MIR212, HIC1, and SMG6, within our newly defined SRO ( Figure 1D ) for these white matter changes, and none has been previously associated with such brain findings.
Most of these genes are not associated with Mendelian disorders, although RTN4RL1, SMG6, MIR132 and MIR212 are expressed in the brain. SMG6 and RTN4RL1 have the highest pLIs (probabilities of loss-of-function intolerance, 13 1.00 and 0.79, respectively) of the SRO genes.
RTN4RL1 regulates axonal and dendritic growth, 14 and it may serve as a receptor for Nogo-66, a myelin-associated inhibitor. 15 Of note, the Nogo-66 receptor gene RTN4R is located in 22q11.21, recurrent deletions of which can cause white matter abnormalities, a phenotype which has been hypothesized to be further modulated by polymorphisms in the nondeleted RTN4R allele.
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SMG6 is involved in mRNA decay. 17 As microRNAs MIR132 and MIR212 are noncoding, pLI scores are not applicable, although attenuation of Mir132 in mice reduces neurite outgrowth.
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It has been hypothesized that HIC1 haploinsufficiency (pLI score not available) contributes to the facial features and heart and gastrointestinal anomalies in Miller-Dieker syndrome, 19 although these features are not prominent in our cohort. Given HIC1's role in precartilaginous tissues and muscle development, 19 this could be a candidate for the hypermobility in our patients.
Additionally, as HIC1 acts as a tumor suppressor, 20 future monitoring of patients with HIC1
deletions for risk of neoplasia is possibly warranted. The remainder of the genes in the SRO have low pLI scores, and two (SERPINF1 and DPH1) are associated with recessive disease (OMIM#613982 and #616901), so it is less likely that these genes are haploinsufficient.
However, as these white matter changes may have minimal outward phenotypic impacts, we cannot rule out the possibility that one of these other genes with more tolerance to loss-offunction contributes to the MRI findings.
When white matter changes are found, long-term follow-up is recommended to evaluate whether the leukoencephalopathy is static. Given the likely presence of such changes in an adult (father of Patients 2-3) and normal development in our patients, some reassurance may be given to 
